Twist Bioscience Corporation
TWST
株式のランク
#2039
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
株価
$152.67
最終同期: 2026-10-21
時価総額
$10.05B
変化（1日）
6.99%
変化（1年）
391.53%
国
US
取引 Twist Bioscience Corporation (TWST)
カテゴリー
Healthcare
Twist Bioscience Corporation（TWST）の株価履歴
終値の最高値: $158.66 （2026-10-01）
終値の最安値: $14.00 （2018-10-01）
終値の最安値: $14.00 （2018-10-01）
Twist Bioscience Corporation の株価履歴（2018 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 129.41% |
| 2025 | -34.20% |
| 2024 | 51.49% |
| 2023 | 28.95% |
| 2022 | -69.99% |
| 2021 | -41.72% |
| 2020 | 492.38% |
| 2019 | 7.82% |
| 2018 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
